Name: Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model (Video) | JoVE Journal
Uploaded: 2019-03-18T13:00:00.000+00:00
Duration: 7 min 3 s
Description: Learn to implant hiPSC-derived cardiac muscle patches after myocardial cryoinjury in guinea pigs. This method enables reproducible infarction models for evaluating engineered heart tissue function and cardiac repair mechanisms.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

No funding was received for this study

Animals received humane care in compliance with the Guide for the Principles of Laboratory Animals, prepared by the Institute of Laboratory Animal Resources, and published by the National Institutes of Health. All animal protocols were approved by the responsible local authority (&#8216;&#8216;Amt f&#252;r Gesundheit und Verbraucherschutz, Hansestadt Hamburg&#8217;&#8217;/ Animal protocol # 109/16).
1. Obtain Animals
<ol>
	<li>Commercially obtain female Guinea pigs weighing 500&#8211;600 g.</li>
	<li>House them under conventional conditions in animal cages. Feed standard rat chow and autoclaved water ad libidum.</li>
</ol>
2. Transthoracic Echocardiography
<ol>
	<li>Place the guinea pig in an induction chamber and anesthetize the animal with isoflurane (2&#8211;3%). Check the depth of anesthesia by lack of response to the toe-pinch.&#160;</li>
	<li>Place the anesthetized Guinea pig on a warming platform (40&#8211;42 &#176;C) in a supine position. Continue anesthesia via a nose cone (isoflurane 1.5-2%)</li>
	<li>Shave and depilate the guinea pig&#180;s thorax using an electric animal hair shaver.</li>
	<li>Apply prewarmed (~25 &#176;C) ultrasound transducer gel. Use an echocardiography system that is equipped with a transducer frequency higher than 15 MHz.</li>
	<li>Acquire two-dimensional parasternal long axis views by placing the transducer on the guinea&#180;s pig thorax facing from the right neck towards the left leg and record long axis B-mode images at the plane of the aortic valve with a concurrent visualization of the LV apex. Investigate the pre-operative left-ventricular function.</li>
	<li>Turn the transducer by 90&#176; degrees to obtain a short axis B-mode view at the mid-papillary level. 
	NOTE: The animal is then immediately transferred to the OR table. The animal is continuously anesthetized with 3% isoflurane. 0.05 mg/kg atropine (i.m.) is injected to avoid increased bronchial secretion during mechanical ventilation.</li>
</ol>
3. Surgery
<ol>
	<li>Induction of Myocardial infarction
	<ol>
		<li>Inject 4&#8211;5 mg/kg carprofen and 0.05 mg/kg buprenorphine for analgesia&#160;subcutaneously with a 21 G needle and a 10 mL syringe.&#160;0.5 mg/kg Atropine is injected subcutaneously with a 21 G needle and a 10 mL syringe.</li>
		<li>Place the guinea pig on its back and keep anesthesia with a facemask covering mouth and nose. Check the depth of anesthesia by pinching the hind feet (lack of pedal reflex).</li>
		<li>Spread the guinea pigs&#8217; legs and fix the position using tape.</li>
		<li>Shave the chest and the tracheal region of the anesthetized animal with an electric shaver. Disinfect the area widely using iodine-based scrub, followed by 80% ethanol. Repeat this disinfection steps twice.</li>
		<li>Perform a 1.5 cm vertical incision in the tracheal area and bluntly dissect the muscles covering the trachea until you see the trachea. Puncture the trachea with 18 G i.v. cannula and insert the flexible part of the cannula as a tracheal tube.</li>
		<li>Connect the tracheal tube to an animal respirator to continuously ventilate the guinea pig during the procedure. 
		NOTE: Now the anesthesia is maintained with isoflurane 3% via the tracheal tube (inspiration assisted ventilation with maximum inspiration pressure, respiration rate: 100&#8211;120/min, peak inspiration pressure: 18-22 cm Hg using PEEP-ventilation while the chest is open).</li>
		<li>Identify the 5th intercostal space by counting the rib spaces beginning at the first intercostal space. Perform a 2 cm horizontal incision on the 5th intercostal space on the left side of the guinea pig using scissors and a tweezer. Insert a small animal retractor. Dissect the muscles with an electrocautery until the intercostal muscles are reached, which can be seen after removing the subcutaneous tissue, are reached.</li>
		<li>Gently dissect the intercostal muscles with tweezers until the pleural space is reached and one can see the left lung in front. Insert the retractor between the ribs and open it carefully until a good view of the heart is obtained.</li>
		<li>Open the pericardium approximately 1 cm in the region of the anterior left ventricular wall with scissors. Place a compress on the left lung to protect it from damage when inducing the cryoinjury of the left ventricle.</li>
		<li>Place the tip of an eroded metal stamp (aluminum)&#160;with a cross-sectional diameter of 0.5 cm into liquid nitrogen for 3 min.</li>
		<li>Press the nitrogen cooled probe onto the left anterior wall of the heart for 30 s. Then separate it from the heart using an electric soldering iron (250 &#176;C) which is placed inside the stamp to warm it up. Repeat this procedure 3 times to obtain a transmural myocardial injury. Observe the blanching of the myocardium.</li>
		<li>Inflate the lungs with maximum pressure (by clamping the outflow tube of the ventilator for 2 s), to avoid atelectasis of the lung. Remove the retractor from the intercostal space.</li>
		<li>Close the ribs with two 3-0 sutures. Close the muscles over the ribs with a 4-0 running suture. For closure of the skin use 5-0 suture single stitches.</li>
		<li>Reduce the isoflurane to 1%. When the animal is breathing spontaneously, remove the tracheal tube, and continue anesthesia with a facemask (isoflurane 2&#8211;3%).</li>
		<li>Assure the absence of reflexes by pinching the hind limb to monitor sufficient depth of anesthesia. Then use a single 8-0 suture to close the puncture site at the trachea. Close the wound with three single stich 4-0 sutures.</li>
		<li>Use buprenorphine (0.05 mg/kg per 12 h) and carprofen (5 mg/kg per 24 h) for pain medication for the following 5 days.</li>
	</ol>
	</li>
	<li>Implantation of EHT (7 days after cryoinjury)
	<ol>
		<li>Place the guinea pig in an induction chamber and anesthetize the animal with isoflurane Check the depth of anesthesia by the lack of response to the toe-pinch.</li>
		<li>Inject 4&#8211;5 mg/kg carprofen and 0.05 mg/kg buprenorphine subcutaneously with a 21 G needle and a 10 mL syringe after induction of anesthesia. Place the guinea pig on its back and keep anesthesia with a facemask covering mouth and nose. 
		NOTE: Sufficiency of anesthesia should be checked by pinching the hind feet.</li>
		<li>Spread the guinea pig&#8217;s legs and fix the position using tape.</li>
		<li>Perform the pre-surgical preparations as described in step 3.1.4&#8211;3.1.6. Perform a 2 cm horizontal skin incision in the scar area of the left lateral side using scissors and tweezers.</li>
		<li>Gently dissect the extrapleural adhesions using an electrocautery. Carefully open the pleural space with scissors. Insert a rib spreader to expose the heart.</li>
		<li>Visually identify the region of the infarction by its pale color in comparison to the healthy surrounding myocardium. Place the engineered heart tissue patch over the infarction region.</li>
		<li>Secure it with two 8-0 sutures at both sides. Make sure to secure the patch in the non-infarcted area of the heart (Figure 1). Inflate the lungs with pressure, to avoid atelectasis of the lung. Remove the retractor from the intercostal space.</li>
		<li>Close the ribs with two 3-0 sutures. Close the muscles over the ribs with a 4-0 running suture. For closure of the skin use 5-0 suture single stitches.</li>
		<li>Reduce the isoflurane to 1%. When the animal is breathing spontaneously, remove the tracheal tube, and continue anesthesia with a facemask (isoflurane 2&#8211;3%).</li>
		<li>Assure the absence of reflexes by pinching the hind limb to monitor sufficient depth of anesthesia. Then use a single 8-0 suture to close the puncture site at the trachea. Close the wound with three single stitch 4-0 sutures.</li>
		<li>Use buprenorphine (0.05 mg/kg per 12 h) and carprofen (5 mg/kg per 24 h) for pain medication for the following 5 days.</li>
		<li>Four weeks after EHT implantation perform a transthoracic echocardiography (as described in step 2) to monitor LV function over time. 
		NOTE: The LV function is monitored before EHT implantation and 4 weeks after implantation to monitor for improvement of cardiac function by EHT implantation</li>
		<li>Euthanize the animal which IACUC approved protocol and surgically explant the heart for further analysis.</li>
	</ol>
	</li>
</ol>

<ol><li>Kirklin, J. K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Seventh+INTERMACS+annual+report%3A+15%2C000+patients+and+counting%5BTitle%5D)+AND+%22The+Journal+of+heart+and+lung+transplantation%3A+the+official+publication+of+the+International+Society+for+Heart+Transplantation%22%5BJournal%5D)">Seventh INTERMACS annual report: 15,000 patients and counting.</a> The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. 34, 1495-1504 (2015).</li>
<li>Soonpaa, M. H., Field, L. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Survey+of+studies+examining+mammalian+cardiomyocyte+DNA+synthesis%5BTitle%5D)+AND+%22Circulation+research%22%5BJournal%5D)">Survey of studies examining mammalian cardiomyocyte DNA synthesis.</a> Circulation research. 83, 15-26 (1998).</li>
<li>Shiba, Y., Hauch, K. D., Laflamme, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cardiac+applications+for+human+pluripotent+stem+cells%5BTitle%5D)+AND+%22Current+pharmaceutical+design%22%5BJournal%5D)">Cardiac applications for human pluripotent stem cells.</a> Current pharmaceutical design. 15, 2791-2806 (2009).</li>
<li>Shiba, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Human+ES-cell-derived+cardiomyocytes+electrically+couple+and+suppress+arrhythmias+in+injured+hearts%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts.</a> Nature. 489, 322-325 (2012).</li>
<li>Chong, J. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Human+embryonic-stem-cell-derived+cardiomyocytes+regenerate+non-human+primate+hearts%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.</a> Nature. 510, 273-277 (2014).</li>
<li>Kattman, S. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Stage-specific+optimization+of+activin%2Fnodal+and+BMP+signaling+promotes+cardiac+differentiation+of+mouse+and+human+pluripotent+stem+cell+lines%5BTitle%5D)+AND+%22Cell+stem+cell%22%5BJournal%5D)">Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines.</a> Cell stem cell. 8, 228-240 (2011).</li>
<li>Watanabe, T., Rautaharju, P. M., McDonald, T. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ventricular+action+potentials%2C+ventricular+extracellular+potentials%2C+and+the+ECG+of+guinea+pig%5BTitle%5D)+AND+%22Circulation+research%22%5BJournal%5D)">Ventricular action potentials, ventricular extracellular potentials, and the ECG of guinea pig.</a> Circulation research. 57, 362-373 (1985).</li>
<li>Weinberger, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cardiac+repair+in+guinea+pigs+with+human+engineered+heart+tissue+from+induced+pluripotent+stem+cells%5BTitle%5D)+AND+%22Science+translational+medicine%22%5BJournal%5D)">Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells.</a> Science translational medicine. 8, 363ra148(2016).</li>
<li>Shiba, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Electrical+Integration+of+Human+Embryonic+Stem+Cell-Derived+Cardiomyocytes+in+a+Guinea+Pig+Chronic+Infarct+Model%5BTitle%5D)+AND+%22Journal+of+Cardiovascular+Pharmacology+and+Therapy%22%5BJournal%5D)">Electrical Integration of Human Embryonic Stem Cell-Derived Cardiomyocytes in a Guinea Pig Chronic Infarct Model.</a> Journal of Cardiovascular Pharmacology and Therapy. 19, 368-381 (2014).</li>
<li>van Laake, L. W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Human+embryonic+stem+cell-derived+cardiomyocytes+survive+and+mature+in+the+mouse+heart+and+transiently+improve+function+after+myocardial+infarction%5BTitle%5D)+AND+%22Stem+cell+research%22%5BJournal%5D)">Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction.</a> Stem cell research. 1, 9-24 (2007).</li>
<li>Zimmermann, W. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Engineered+heart+tissue+grafts+improve+systolic+and+diastolic+function+in+infarcted+rat+hearts%5BTitle%5D)+AND+%22Nature+medicine%22%5BJournal%5D)">Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts.</a> Nature medicine. 12, 452-458 (2006).</li>
<li>Johns, T. N., Olson, B. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Experimental+myocardial+infarction.+I.+A+method+of+coronary+occlusion+in+small+animals%5BTitle%5D)+AND+%22Annals+of+surgery%22%5BJournal%5D)">Experimental myocardial infarction. I. A method of coronary occlusion in small animals.</a> Annals of surgery. 140, 675-682 (1954).</li>
<li>van den Bos, E. J., Mees, B. M., de Waard, M. C., de Crom, R., Duncker, D. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+novel+model+of+cryoinjury-induced+myocardial+infarction+in+the+mouse%3A+a+comparison+with+coronary+artery+ligation%5BTitle%5D)+AND+%22Heart+and+circulatory+physiology%22%5BJournal%5D)">A novel model of cryoinjury-induced myocardial infarction in the mouse: a comparison with coronary artery ligation.</a> Heart and circulatory physiology. , H1291-H1300 (2005).</li>
</ol>

None of the authors has competing financial interests or other conflicts of interest to declare.

A variety of small animal models are available to study the effect that cell transplantation exerts on injured hearts9,10,11. We chose a guinea pig model because of all small animal models its (electro)physiology resembles most closely that of humans. The advantages of small animal models are simple housing, manageable costs, and few workforces. In comparison with mice and rats, guinea pigs&#180; cardiac (electro)physiology is m...

The number of patients with heart failure is increasing in our aging population. For end-stage heart failure, orthotopic heart transplantation is the only curative treatment option. However, especially in European countries, there is an increasing organ donor shortage. Therefore, alternative treatment options are necessary. Recent achievements in mechanical circulatory support are promising, but especially in the long-term run, limited by its side effects like bleeding, pump thrombosis and infectious complications1.
The endogenous regeneration capacity of the adult human heart is extremely limited. Therefore, cardiac regeneration therapies might become an alternative treatment option for end-stage heart failure patients2,3. Different techniques including stem cell-based cell injection or tissue engineering approaches have been described3,4,5.
Human induced pluripotent stem cells (hiPSC), as well as human embryonic stem cells (hESC) can be effectively differentiated to spontaneously beating human cardiomyocytes6, which has been a major achievement in the field of cardiac regenerative therapies.
To replace myocardium after a myocardial infarction and to improve the function of a failing heart, survival of a suitable number of cardiomyocytes and their mechanical and electrical coupling with the native heart is essential. To investigate the potential of cardiac regenerative therapies with human iPS cell derived cardiomyocytes, a suitable research model is needed. The ideal model should be cost-effective and have a human-like physiology and electrophysiology. Large animal models like pigs would be ideal from that point of view, however, those experiments are very expensive and large amounts of cardiomyocytes would be necessary to replace a relevant number of cardiomyocytes in order to see effects on the left ventricular function in a pig infarction model.
To answer elementary biological questions towards human cell-based cardiac regeneration, e.g., cell survival, vascularization, and electrical coupling, small animal models are more suitable. From the available small animal models, the guinea pig is the most useful species, as compared to rats and mice, as their electrophysiology more closely resembles the situation in humans7. In this guinea pig model, we induced a transmural cryoinjury of the left ventricle. One week after induction of myocardial infarction implantation of a three-dimensional, spontaneously beating hiPS-cell derived cardiomyocyte patch was performed. Cardiomyocyte cell survival was evaluated 28 days after implantation by histological examination.

<table><tbody><tr><td>Ventilator (VetFlo Dual Mode)</td><td>Kent Scientific</td><td></td><td></td></tr><tr><td>Forene</td><td>abbvie</td><td>1000009819</td><td></td></tr><tr><td>Carprofen</td><td>Zoetis</td><td>256692</td><td></td></tr><tr><td>Atropin</td><td>Braun</td><td>PZN 00648037</td><td></td></tr><tr><td>Buprenorphin</td><td>Sigma</td><td></td><td></td></tr><tr><td>Metal stamp</td><td></td><td></td><td></td></tr><tr><td>Electric soldering iron</td><td>Claytools</td><td></td><td></td></tr><tr><td>3-0 prolene suture</td><td>Ethicon</td><td></td><td></td></tr><tr><td>4-0 prolene suture</td><td>Ethicon</td><td>662SLH</td><td></td></tr><tr><td>5-0 prolene suture</td><td>Ethicon</td><td>8710H</td><td></td></tr><tr><td>8-0 prolene suture</td><td>Ethicon</td><td>8841H</td><td></td></tr><tr><td>Tungsten Carbide Scissor&amp;nbsp;</td><td>FST</td><td>No. 14568-12</td><td></td></tr><tr><td>Stainless sterilization Container</td><td>FST</td><td>No. 20890-51</td><td></td></tr><tr><td>Graefe Forceps</td><td>FST</td><td>No.11652-10</td><td></td></tr><tr><td>Extra fine Graefe Forceps</td><td>FST</td><td>No.11150-10</td><td></td></tr><tr><td>Forceps</td><td>FST</td><td>No. 11022-15</td><td></td></tr><tr><td>Halsted- Mosquito</td><td>FST</td><td>No. 13009-12</td><td></td></tr><tr><td>Forceps</td><td>FST</td><td>No.13003-10</td><td></td></tr><tr><td>Baby Mixter</td><td>FST</td><td>No. 13013-14</td><td></td></tr><tr><td>Needle holder (Castroviejo with Tungsten Casbide Jaws)&amp;nbsp;</td><td>FST</td><td>No. 12565-14</td><td></td></tr><tr><td>Needle Holder (Halsey)</td><td>FST</td><td>No. 12501-13</td><td></td></tr><tr><td>Alm Retractor with Blumt Teeth</td><td>FST</td><td>No. 17008-07</td><td></td></tr><tr><td>Spring Scissor</td><td>FST</td><td>No. 15000-00</td><td></td></tr><tr><td>Compress 5x5</td><td>Fink + Walter</td><td>PZN 08821417</td><td></td></tr><tr><td>Venflon Pro Safety</td><td>Becton Dickinson</td><td>PZN11123964</td><td></td></tr><tr><td>Cautery High Temp 2&quot;</td><td>Bovie Medical Corporation</td><td>0100607151011055</td><td></td></tr></tbody></table>

implantation of hipsc-derived cardiac-muscle patches after myocardial injury in a guinea pig model

Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model

Due to the limited regeneration capacity of the heart in adult mammals, myocardial infarction results in an irreversible loss of cardiomyocytes. This loss of relevant amounts of heart muscle mass can lead to the heart failure. Besides heart transplantation, there is no curative treatment option for the end-stage heart failure. In times of organ donor shortage, organ independent treatment modalities are needed. Left-ventricular assist devices are a promising therapy option, however, especially as destination therapy, limited by its side-effects like stroke, infections and bleedings. In recent years, several cardiac repair strategies including stem cell injection, cardiac progenitors or myocardial tissue engineering have been investigated. Recent improvements in cell biology allow for the differentiation of large amounts of cardiomyocytes derived from human induced pluripotent stem cells (iPSC). One of the cardiac repair strategies currently under evaluation is to transplant artificial heart tissue. Engineered heart tissue (EHT) is a three-dimensional in vitro created cardiomyocyte network, with functional properties of native heart tissue. We have created EHT-patches from hiPSC derived cardiomyocytes. Here we present a protocol for the induction of left ventricular myocardial cryoinjury in a guinea pig, followed by implantation of hiPSC derived EHT on the left ventricular wall.

This guinea pig model is a suitable model to investigate cardiac regeneration after implantation of hiPSC derived EHT-patches. It reproducibly leads to large transmural myocardial injuries. Scar size is evaluated by histology four weeks after cryoinjury. Mason trichrome staining reveals large transmural scars (Figure 2). Scar size was similar over a large number of injured animals reflecting a high degree of reproducibility8. On average 25% of the left ventricular myo...

Here we present a protocol for the induction of left ventricular cryoinjury followed by the implantation of a cardiac muscle patch, derived from human iPS-cell cardiomyocytes in a guinea pig model.

Due to the limited regeneration capacity of the heart in adult mammals, myocardial infarction results in an irreversible loss of cardiomyocytes. This loss ...

implantation-hipsc-derived-cardiac-muscle-patches-after-myocardial

Research

JoVE Journal

Medicine

Intramyocardial cell delivery in murine models of cardiovascular diseases, such as hypertension or myocardial infarction, is widely used to test the therapeutic potential of different cell types in regenerative studies. Therefore, a detailed description and a clear visualization of this surgical procedure will help to define the limits and advantages of cardiovascular cell therapeutic analyses in small rodents.

Intramyocardial Cell Delivery: Observations in Murine Hearts

Implantation of a biograft to treat myocardial infarction induced by LAD ligation in a rodent model has conventionally required two open-heart surgeries. In order to reduce mortality and provide optimal conditions for fixation of solid and gelatinous biomatrices associated with cells, minimally invasive procedures have been developed.

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

This protocol aims to alleviate the limitation of poor cell engraftment for stem cell treatment of myocardial infarctions through the use of a hydrogel system and a fibrin-based glue. With this approach, cell-to-tissue contact post-infarction can be maintained, increasing the therapeutic potential of beneficial agents at the site of injury.

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.

We present three novel and more efficient protocols for differentiating human induced pluripotent stem cells into cardiomyocytes, endothelial cells, and smooth muscle cells and a delivery method that improves the engraftment of transplanted cells by combining cell injection with patch-mediated cytokine delivery.

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

We sought to establish a swine model of heart failure induced by left circumflex artery blockage and rapid pacing to test the effect and safety of intramyocardial administration of stem cells for cell-based therapies.

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

This protocol aims to transplant a 3D bioprinted patch onto the epicardium of infarcted mice modeling heart failure. It includes details regarding anesthesia, the surgical chest opening, permanent ligation of the left anterior descending (LAD) coronary artery and application of a bioprinted patch onto the infarcted area of the heart.

Transplantation of a 3D Bioprinted Patch in a Murine Model of Myocardial Infarction

We describe a sterile pericarditis model in minipigs to study atrial myopathy and atrial fibrillation (AF). We present surgical and anesthetic techniques, strategies for vascular access, and a protocol to study the inducibility of AF.

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Ultrasound-guided cell delivery around the site of myocardial infarction in mice is a safe, effective, and convenient way of cell transplantation.

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

The present protocol describes three methods of administering cardioactive therapeutic agents in a porcine model. Female landrace swine received treatment through either: (1) thoracotomy and transepicardial injection, (2) catheter-based transendocardial injection, or (3) intravenous infusion via jugular vein osmotic minipump.

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

This study presents a surgical porcine model of chronic myocardial ischemia due to progressive coronary artery stenosis, resulting in impaired cardiac function without infarction. Following ischemia, animals undergo off-pump coronary artery bypass graft with epicardial placement of stem cells-derived exosomes-laden collagen patch. This adjunctive therapy improves myocardial function and recovery.

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

This study proposes a preclinical orthotopic heart transplantation model in Bama miniature pigs, utilizing the biatrial technique. The model is applicable for transplant immunology, drug evaluation, and surgical technique optimization, providing support for clinical heart transplantation applications.

A Preclinical Model of Orthotopic Heart Transplantation in Bama Miniature Pigs Using Biatrial Technique

Learn to implant hiPSC-derived cardiac muscle patches after myocardial cryoinjury in guinea pigs. This method enables reproducible infarction models for evaluating engineered heart tissue function and cardiac repair mechanisms.

Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model

Explore More Videos